Nurse Intervention Approach Feasible in Addressing Cancer Symptom Clusters
A pilot study proved that a nurse-coordinated approach shows promise in treating more than just 1 symptom among patients with cancer.
A pilot study proved that a nurse-coordinated approach shows promise in treating more than just 1 symptom among patients with cancer.
Developers will work with investigators of the phase 3 KEYNOTE-B21 trial to share their findings with the scientific community.
This single-center cohort study assesses the association of tumor mutational burden status in patients with metastatic castration-resistant prostate cancer and response to immune checkpoint inhibitor…
Experts from the University of Wisconsin Health discuss ongoing barriers to equitable cancer care and ways to drive change.
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
We have noticed an unusual activity from your IP 199.16.157.183 and blocked access to this
Submission gap and review time for oncology applications at Swissmedic were significantly reduced by participation in Project Orbis, and approval consensus decisions were increased between…
Thursday, 13 June, 2024 5:00 – 6:30 PM CEST Room Name: Dali 2 Hall IFEMA Madrid Recinto Ferial (Fairgrounds) Av. del Partenón, 5, Barajas, 28042…
R. Wendel Naumann, MD, discusses 2 case studies in platinum-resistant ovarian cancer and the optimal treatment approaches for each patient.
Nature Reviews Cancer – In this Review, Paul et al. provide an overview of therapeutic antibodies as an important modality in cancer therapy today. They…
On October 31, 2023, pembrolizumab (Keytruda) was approved for use with gemcitabine/cisplatin in first-line treatment of patients with locally advanced unresectable or metastatic biliary…